Pain Therapeutics Inc. About
Pain Therapeutics Inc. Pain Therapeutics is a biopharmaceutical
company that develops novel drugs. Their drugs target severe chronic pain,
such as pain
associated with advanced osteoarthritis,
low-back pain or irritable
bowel syndrome. Pain Therapeutics has three proprietary drug candidates
in clinical development: Oxytrex™, Remoxy™ and PTI-901. Pain
Therapeutics believe the target market for these three drug candidates exceeds
$3 billion per year. OXYTREX -- treat severe chronic pain, such
as low back, osteoarthritic pain or cancer pain REMOXY --is a proprietary
abuse-resistant version of time-release oxycodone PTI-901 --treats
chronic Irritable
Bowel Syndrome (IBS). PTI-901 is a proprietary drug candidate that consists
of an oral low-dose opioid antagonist More
About Pain Therapeutics Key
Statistics for Pain Therapeutics
Basic
Chart for Pain Therapeutics